World Orphan Drug Alliance (WODA) is a new global alliance of full-service regional distributors for orphan drugs. WODA covers 68 countries on 4 continents.There are more than 64 million potential
Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla Agreement enables expanded patient access of the only EU-approved treatment for myotonia symptoms in non-dystrophic myotonic
Medis Group ends its 2020 financial year with almost 12% revenue growth
LJUBLJANA, Slovenia, Feb. 18, 2021 /PRNewswire/
Pharmaceutical company Medis as a part of Medis Group ended its 2020 financial year with revenues of € 136.1 million, up 11.9 percent from the previous year. Growth was particularly noticeable in foreign markets, where most of the revenue was generated. The highest growths in sales revenue were achieved in Austria, Hungary, Serbia and the Baltic States, while growth of more than 9% was achieved in Slovenia. In addition, value added per employee also went up to € 112.000. Medis has enjoyed average revenue increases of nearly 16 percent annually for the past five years.